Description: Sequana Medical NV, a commercial stage medical device company, engages in the development of platform for the treatment of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally. The company was founded in 2006 and is headquartered in Ghent, Belgium.
Home Page: www.sequanamedical.com
Kortrijksesteenweg 1112
Gent,
9051
Belgium
Phone:
32 9 298 28 28
Officers
| Name | Title |
|---|---|
| Mr. Ian Crosbie | CEO & Exec. Director |
| Ms. Kirsten Van Bockstaele | Chief Financial Officer |
| Ms. Lies Vanneste | Director of Investor Relations |
| Mr. Gijs Klarenbeek | Chief Medical Officer |
| Mr. Martijn Blom | Chief Commercial Officer |
| Dr. Oliver Godje M.D., Ph.D. | Chief Medical Officer |
Exchange: BR
Country: BE : Belgium
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 11.5189 |
| Price-to-Sales TTM: | 182.3852 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 60 |